Back
Zymeworks, Inc. Vs. Merck & Co., Inc. Industry Stock Comparison
Buy
69
ZYME
Zymeworks, Inc.
Last Price:
$26.73
Seasonality Move:
-5.1%
Buy
68
MRK
Merck & Co., Inc.
Last Price:
$106.88
Seasonality Move:
0.72%
Buy
69
Zymeworks, Inc. (ZYME)
is a Buy
Is Zymeworks, Inc. a Buy, Sell or Hold?
-
The current Zymeworks, Inc. [ZYME] share price is $26.87. The Score for ZYME is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
ZYME is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
68
Merck & Co., Inc. (MRK)
is a Buy
Is Merck & Co., Inc. a Buy, Sell or Hold?
-
The current Merck & Co., Inc. [MRK] share price is $106.78. The Score for MRK is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
-
MRK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ZYME Stock Price Chart
What is Zymeworks, Inc.'s stock price today?
-
The Zymeworks, Inc. share price today is $26.87Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZYME is experiencing buying pressure, which is a positive indicator for future bullish movement.
MRK Stock Price Chart
What is Merck & Co., Inc.'s stock price today?
-
The Merck & Co., Inc. share price today is $106.78Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MRK is experiencing slight buying pressure.
ZYME Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.34 | Buy |
| Relative Strength Index (14 RSI): | 61.78 | Buy |
| Chaikin Money Flow: | 128289 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.12 - 26.98) | Buy |
| Bollinger Bands (100): | (14.42 - 23.56) | Buy |
MRK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.75 | Buy |
| Relative Strength Index (14 RSI): | 70.87 | Buy |
| Chaikin Money Flow: | 2955298 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (98.06 - 104.28) | Buy |
| Bollinger Bands (100): | (81.29 - 96.97) | Buy |
ZYME Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.65 | Buy |
| 20-day SMA: | 26.25 | Buy |
| 50-day SMA: | 22.51 | Buy |
| 200-day SMA: | 15.67 | Buy |
| 8-day EMA: | 22.25 | Buy |
| 20-day EMA: | 13.51 | Buy |
| 50-day EMA: | 6.54 | Buy |
| 200-day EMA: | 1.81 | Buy |
MRK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 102.78 | Buy |
| 20-day SMA: | 101.29 | Buy |
| 50-day SMA: | 94.6 | Buy |
| 200-day SMA: | 85.42 | Buy |
| 8-day EMA: | 103.76 | Buy |
| 20-day EMA: | 101.1 | Buy |
| 50-day EMA: | 96.15 | Buy |
| 200-day EMA: | 90.65 | Buy |
Zymeworks, Inc. Earnings Growth & ZYME Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.57 per share, and an increase next year of $1.15 per share.
Merck & Co., Inc. Earnings Growth & MRK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.36 per share, and a decrease next year of $0.68 per share.
Zymeworks, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Merck & Co., Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||